bioRxivCell BiologyPreprint
Hemoglobin C is prone to oxidative denaturation, resulting in red blood cell membrane damage in HbSC disease
Tahereh SetayeshiD, Anifat TijaniiD, Harsimran KauriD, Shristi KhanaliD, Zhenqi ZhuiD, Zachery OestreicheriD, Katie Giger SeuiD, József BallaiD, Mengna ChiiD, Russell E. WareiD, Punam MalikiD
Abstract
Sickle-hemoglobin-C (HbSC) sickle cell disease is characterized by RBC dehydration (xerocytosis), which promotes polymerization of HbS. HbSC causes substantial morbidity despite lower sickling potential than HbSS, suggesting a critical detrimental role of HbC in the disease pathophysiology. We derived HbCC mice by interbreeding our HbSC mice, which demonstrated a similar RBC phenotype of xerocytosis as humans with HbCC. We compared RBCs from HbCC, HbSC, and HbSS mice. Oxidized ferryl (Fe4+)-Hb, and its oxidative-denaturation, which results in hemichrome formation (Heinz-bodies), was most pronounced in HbCC>HbSC>HbSS, despite significantly higher reactive oxygen species in HbSS, illustrating a higher propensity of HbC to denaturation than HbS. RBC deformability followed a similar pattern, with Elongation Index lowest in HbCC<HbSC<HbSS. Next, we determined if RBC from HbSC patients on hydroxyurea showed improved membrane damage. Hydroxyurea treatment reduced Heinz-body formation and improved RBC deformability, despite negligible/modest fetal hemoglobin (HbF) induction, compared to non-hydroxyurea HbSC controls. The antioxidant quercetin showed a similar reduction in Heinz-body burden and improvement in RBC deformability as hydroxyurea, without affecting Hb or HbF concentration, reticulocyte count, or RBC xerocytosis. HbC-driven oxidative denaturation and membrane damage represent important contributors of RBC dysfunction in HbSC disease; hence, oxidative membrane injury could be targeted besides antisickling approaches.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural insights into the inhibition of sickle hemoglobin polymerization by asymmetric hemoglobin tetramer HbFS (α2γβS)
Aastha Baliyan, Neha Yadav, … Amit Kumar Mandal·bioRxiv·Jun 7, 2026
- In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction
A. D'Alessandro, M. Nouraie, … M. T. Gladwin·bioRxiv·Feb 13, 2023
- Isoquercetin treatment of mouse sickled red blood cells shows a discernible deformability and sickling phenotype
Osamede C. Owegie, Iván Hancco Zirena, … Moua Yang·bioRxiv·Apr 28, 2026
- Biophysical Basis of Hb-S Polymerization in Red Blood Cell Sickling
W. Li·bioRxiv·Jun 21, 2019
- Enhanced PIEZO1 Function Contributes to the Pathogenesis of Sickle Cell Disease
Luis O. Romero, Manisha Bade, … Valeria Vásquez·Proceedings of the National Academy of SciencesPeer-reviewed·Oct 2, 2025
- Therapeutic potential of oxygen through M101 transportation in reducing vaso-occlusion and hemolysis in a mouse model of sickle cell disease.
Franck Zal, Rachel Rignault‐Bricard, … Thiago Trovati Maciel·bioRxiv·Jun 18, 2025